VTE Treatment and Renal Impairment

VTE Treatment and Renal Impairment

2020-05-25 Bayer

PE/ DVT or VTE treatment initiation and treatment extension for patients with renal impairment; Patients with renal impairment are at high risk of VTE recurrence and bleeding events; Find out how to treat high risk VTE patients with renal impairment

Videos filtered by:

No video present for this selection.

© 2020 Bayer AG

This website contains information on Xarelto (rivaroxaban) which is based on the Summary of Product Characteristics (SPC) as approved by the European Commission. It is intended to provide information to an international audience outside the USA and UK.

  • PP-XAR-ALL-0563-1
Last updated on 25/05/2020